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Reviewer #2  
 
The explanations offered by the authors are adequate. 
 
Thank you to the reviewer for acknowledging our previous response to 
reviewers’ comments as adequate. 
 
Reviewer #3  
 
While the reviewers generally recognize the new and interesting contributions to 
knowledge provided by this paper several specific deficiencies are identified.  In 
response the authors have added sections to the paper with additional references to 
address these deficiencies. In particular reviewers have indicated that young cohorts 
of wild type and transgenic mice should have been included in the study.  The 
authors acknowledge this but cite previously published work to provide support for 
their speculative assertions that synaptophysin staining may be generally reduced in 
brains of aged wild type mice in their experiments. 
 
Where it was possible to do so the authors have responded well to comments made 
by the reviewers by including additional data, figures, text and citations. This includes 
additional details of data analysis in the statistics section and the addition of Figure 7. 
The authors acknowledge that their future studies should include the younger age 
cohorts, more discrete studies including regional brain areas and examining changes 
in microglia. 
 
As with most large studies that employ multiple sensitive techniques it will always be 
possible to identify interesting additions that might have been included if time and 
funds were available however the reality is that these are often limited.  
 
Thank you to the reviewer for their comments and for their appreciation for the 
limitations that were acknowledged in our previous response to reviewers’ 
comments and in the manuscript itself. As noted by this reviewer, we added 
data, analysis, text and citations that we hope helps support our conclusions. 
 
Reviewer #4  
 
In the revision, the authors have addressed several of the issues raised with the 
initial reviews. However, one major issue that remains is the absence of young 
cohort of WT and APP/PS1 mice. This absence is very significant and, apparently, 
can not be addressed by the authors. 
 
Because there is some value in the aged WT vs APP/PS1 comparison, the entire 
manuscript should be completely restructured, streamlined, and focused solely on 
this comparison. The extremely limited data of young WT mice is a distraction, not an 
addition to the aged mice data. Data interpretation and discussion should also be 
limited to the contributions of the APP/PS1 genotype to differences between the 
aged WT and APP/PS1 animals. 
 
Thank you to the reviewer for these helpful comments. The authors agree that 
our limited young data distracts from the aged data and detracts from the 
overall story of the manuscript, however, we feel that this young data is 
nevertheless of value here. We suggest that removing the young data from the 
*Response to Reviewers Resubmission 2
main figures and condensing it into one supplementary figure may adequately 
address these concerns, while allowing the young data to be included in the 
article as supportive to the aged data, rather than as part of the main narrative. 
To this end, we removed the young data from figures 5 and 6, we added one 
supplementary figure consisting of 4 panels and made adjustments to the text 
in the following sections of the manuscript to reflect these changes: 
 Abstract 
 Results; 3.1.4 Peripheral insulin sensitivity and glucose tolerance and 
inflammatory and insulin signaling gene expression in brains of aged 
APP/PS1 mice 
 Results; 3.1.5 Cytokine levels in brains of aged APP/PS1 mice 
 Discussion 
 
The authors feel that these changes have improved the manuscript and 
reiterate our thanks to the reviewer for their insight. However, should the 
reviewer and/or the editor feel that our response was inadequate and would 
prefer if the young data was removed entirely, then we would be happy to 
oblige and remove it. 
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Abstract 
Cognitive dysfunction and neuroinflammation are typical in Alzheimer’s disease (AD), but 
are also associated with normal aging, albeit less severely. Insulin resistance in the brain has 
been demonstrated in AD patients and is thought to be involved in AD pathophysiology. 
Using 15-18 month-old APP/PS1 mice, this study measured peripheral and central insulin 
signaling and sensitivity, inflammatory markers in brain and plasma and oxidative stress and 
synapse density in the brain. Novel object recognition, Morris water maze and reversal water 
maze tasks were performed to assess cognitive function in aged APP/PS1 mice and wild type 
littermates. Glucose tolerance and insulin sensitivity were similar in APP/PS1 mice and wild 
type controls, however IRS-1 pSer
616
 was increased in cortex and dentate gyrus of APP/PS1 
mice. Recognition and spatial memory was impaired in both APP/PS1 and wild type mice, 
however learning impairments were apparent in APP/PS1 mice. Expression of GLP-1 
receptor, ERK2, IKK, mTOR, PKCθ, NF-B1 and TLR4 was similar between aged 
APP/PS1 mice and age-matched wild types. Compared to age-matched wild type mice, IFN 
and IL-4 were increased in brains of APP/PS1 mice. These results suggest that normal aging 
may be associated with enhanced neuroinflammation, oxidative stress, and cognitive decline, 
however distinctions are apparent in the brain of APP/PS1 mice in terms of inflammation and 
insulin signaling and in certain cognitive domains. Demarcation of pathological events that 
distinguish AD from normal aging will allow for improvements in diagnostic tools and the 
development of more effective therapeutics.  
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Keywords: Alzheimer’s disease; aging; neuroinflammation; insulin signalling; cognitive 
function; learning; memory; insulin sensitivity; cytokines 
 
Abbreviations: A Amyloid- AD Alzheimer’s disease ERK2 extracellular signal-regulated 
kinase 2 IKK Inhibitor of NF-B kinase  IRS-1 pSer616 Insulin receptor substrate-1 
phosphorylated at serine residue 616 MAPK mitogen-activated protein kinase mTOR 
mechanistic target of rapamycin MWM Morris water maze ORT Novel object recognition 
task PKC Protein kinase C RI Recognition index RWM Reversal water maze TLR4 Toll-
like receptor 4 
 
1 Introduction 
As healthcare improves around the world, life expectancy continues to rise (1). Accordingly, 
the past 25 years have seen a dramatic increase in disorders associated with aging, including 
neurological diseases such as Alzheimer’s disease (AD) (1), for which advancing age is the 
principal risk factor (2).  
Many clinical and neuropathological features of AD parallel the normal progression 
of aging, making differentiation between normal brain aging and early-stage AD difficult. 
Generally, it can be said that healthy aging is associated with moderate decline in some 
cognitive abilities, whilst AD is characterized by severe deterioration of the same cognitive 
domains, with additional progressive decline of further cognitive functions, such that the 
patient’s daily life is adversely affected to a severe degree (3). In AD, amyloid- (A) 
accumulates into progressively larger fibrils, which become deposited as insoluble plaques in 
the brain parenchyma (4). Accumulating evidence suggests that the presence of A fibrils 
and plaques is not uncommon in the brains of non-demented, cognitively healthy older 
people (5, 6). Several studies have also shown that A deposition does not correlate with 
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cognitive impairment in elderly cohorts (6), highlighting the variability of age-related 
cognitive decline and suggesting that A per se does not directly influence cognitive 
function.  
Profound inflammation is evident in AD brain (7), primarily mediated by microglia 
and astrocytes (8, 9). Activated microglia and astrocytes phagocytose A oligomers and 
fibrils, degrade A plaques and reduce amyloid burden (10, 11). However, sustained 
microglial activation and unresolved inflammation in the brain is harmful to neurons and 
synapses and promotes chronic dysregulation of glial cells and subsequent deterioration of 
brain structure and function (12, 13). Inflammation in the brain increases with age (14) and 
several studies have shown elevated levels of inflammatory cytokines in the brains of aged 
rodents (15, 16). In the context of AD, primed microglia respond more readily to A, 
producing increased levels of cytokines that exert direct toxic effects on neurons and at 
synapses (17).  
Insulin resistance has been demonstrated in postmortem brain tissue from AD patients 
and those with mild cognitive impairment, in the absence of diabetes and irrespective of 
ApoE-ε4 status (18). Furthermore, IRS-1 pSer616 was identified as a putative biomarker of 
brain insulin resistance in AD and was found to correlate positively with A oligomer levels 
and negatively with cognitive function (18). Additionally, Bomfim et al. (19) demonstrated 
increased levels of IRS-1 pSer
616 
in the hippocampus of 13 month-old APP/PS1 mice. Other 
studies have also demonstrated impaired neuronal insulin signaling in AD brain and in 
response to A oligomer challenge (20, 21). 
This study sought to determine differences in learning and memory, oxidative stress, 
glucose tolerance, central and peripheral insulin sensitivity between 15-18 month old wild 
type and age-matched APP/PS1 mice. Using novel object recognition and Morris water maze 
tasks, cognitive function was measured in aged wild type and APP/PS1 mice. Systemic 
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insulin sensitivity and glucose tolerance were compared between groups. Brain levels of A, 
GFAP, 8-oxoguanine, IRS-1 pSer
616
 and synaptophysin were measured by 
immunohistochemistry. Additionally inflammatory and insulin signalling associated genes, 
GLP-1R, IKK, ERK2, mTOR, NF-B1, PKCθ, and TLR4 and inflammatory cytokines 
(IFN, IL-10, IL-1, IL-12p70, IL-2, IL-4, IL-5, IL-6 and KC/GRO (CXCL1)) were assessed 
in brain tissue from aged APP/PS1 and wild type mice to delineate pathological changes from 
those associated with ‘normal’ aging. 
2 Materials and Methods 
2.1.1 Animals 
Male APPswe/PS1Δe9 (APP/PS1) mice with a C57Bl/6J background were bred with wild type 
C57Bl/6J females at the Biomedical and Behavioural Research Unit at Ulster University in 
Coleraine. Offspring were ear punched and positivity for the APPswe/PS1Δe9 transgene, or 
lack thereof was confirmed by polymerase chain reaction, using primers specific for the APP 
sequence of the APP/PS1 construct (Forward “GAATTCCGACATGACTCAGG”, Reverse: 
“GTTCTGCTGCATCTTGGACA”). Offspring males heterozygous for the APPswe/PS1Δe9 
transgenic construct were then age-matched with wild type littermates, not expressing the 
transgene, which were used as controls. Both groups of mice were caged individually and 
allowed access to food and water ad libitum. Animals were maintained on a 12:12 light-dark 
cycle (lights on at 08:00, lights off at 20:00), within a temperature-controlled room (T: 
21.5°C ± 1°C). All tests were performed during the light cycle. All experiments were 
designed, analyzed and reported in accordance with ARRIVE guidelines. Experiments were 
licensed according to UK Home Office regulations (UK Animals Scientific Procedures Act 
1986) and associated guidelines (EU Directive 2010/63/EU). C57Bl/6 mice were derived 
from a colony maintained in the Biomedical and Behavioural Research Unit at Ulster 
University in Coleraine.  
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2.1.2 Glucose tolerance and insulin sensitivity tests 
After an overnight fasting period, APP/PS1 mice and age-matched wild types received an i.p. 
injection of glucose (18 mmol/kg bw) in 0.9% NaCl or insulin (0.25 M/g). Blood glucose 
was measured at 0, 15, 30 and 60 minutes following glucose or insulin injection using a 
hand-held Ascencia Contour blood glucose meter (Bayer Health Care).  
 
2.1.3 Behavioural Assessment 
Mice were assessed in the ORT, as described previously (22). Briefly, mice were subjected to 
a 10 minute acquisition period, with two identical objects, followed by a 3 hour retention 
period and a 10 minute test phase, which involved replacing one of the objects with a novel 
object. A recognition index (RI) was calculated for each object, defined as amount of time 
spent exploring object A or B over the total time spent exploring both objects x 100 (tA or 
tB/(tA + tB) x 100).  
Following ORT, mice were assessed in the Morris water maze (MWM) (22). The 
acquisition training phase consisted of 4 x 90 second trials per day, for 4 consecutive days, 
followed by a probe trial on the fifth day. The day after the probe trial, mice were subjected 
to reversal water maze (RWM), wherein the escape platform was moved from the southwest 
to northwest quadrant. There were 4 trials per day, for 4 consecutive days, followed by a 
reversal probe trial on day 5. 
 
2.1.4 Immunohistochemistry 
Following sacrifice, animals were perfused with PBS and brains excised. One hemisphere 
was fixed in 4% paraformaldehyde and the other was frozen in liquid nitrogen. Hemi-brains 
for histology were then transferred to 30% sucrose and 40 m coronal sections were cut 
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using a cryostat (Leica Microsystems). One section in every 6 was collected sequentially and 
stored at -20C. Staining was performed for A, GFAP, 8-oxoguanine, IRS-1 pSer616 and 
synaptophysin. All sections were incubated in H2O2  and permeabilized using Triton X. For 8-
oxoguanine, sections were incubated at 37°C for 30 minutes with 2 M hydrochloric acid, 
followed by 0.1 M borax (Sigma Aldrich) for 10 minutes. Blocking with 1.5%-10% normal 
serum was performed prior to incubation with anti-A (1:200; Invitrogen; 71-5800) anti-
GFAP (1:250; Merck Millipore; MAB3402), anti-8-oxoguanine (1:250; Merck Millipore; 
MAB3560), anti-IRS-1 pSer
616
 (1:200; Invitrogen; 44-550G) or anti-synaptophysin (1:200; 
Abcam; ab7837) antibodies overnight at 4°C. Sections were then incubated with secondary 
antibodies and visualized using Vectastain Elite and SG substrate (Vector Laboratories). 
Percentage area stained in each image was quantified using a multi threshold plug-in within 
Image J (NIH, Bethesda, USA) in a blinded manner. 
 
 
 
2.1.5 Quantitative polymerase chain reaction (qPCR) 
RNA was extracted from brain tissue using RNeasy Lipid Tissue Mini Kit (Qiagen) 
according to manufacturer’s instructions. For cDNA synthesis, transcriptor First Strand 
cDNA synthesis kit (Roche Diagnostics) was used using 500 ng of RNA per sample. Real-
time PCR reactions were composed of; 5 μl of PCR MasterMix (Roche Diagnostics), 1 μl (10 
pM/l) gene-specific probes, 3 μl of RNase free water and 1 μl (25ng) of template cDNA. 
Gene-specific probes (Roche Diagnostics) were as follows: GLP-1R (Glp1r), IKK (Ikbkb), 
ERK2 (Mapk1), mTOR (Mtor), NF-B1 (Nfkb1), PKCθ (Prkcq) and TLR4 (Tlr4). 
Quantitative PCR was performed on Lightcycler 480 system (Roche Diagnostics), and 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
quantified on accompanying software package (Roche, Lightcycler 480 software, v1.5). Gene 
expression changes were calculated using Delta Delta CT mathematical model (23). 
 
2.1.6 Meso Scale Discovery multi-array 
Whole hemi-brains were homogenized under liquid nitrogen, followed by addition of 10 ml/g 
of lysis buffer (1 mM EDTA in PBS supplemented with protease inhibitor cocktail). Samples 
were centrifuged at 14,000 G for 20 min at 4°C and supernatant was removed and added to 
Meso Scale Discovery (MSD
®
) plate. Bradford protein assay was performed to measure 
protein content and data were normalized to the total amount of protein present in each 
sample. Levels of IFN, IL1, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, TNF- and KC/GRO 
(CXCL1) were quantified in brain and plasma using MSD
®
 Multi-spot Assay Pro-
inflammatory panel 1 kit (Rockville, MD, USA) according to manufacturer’s instructions.  
 
2.1.7 Statistical Analysis 
Data were analyzed using Graphpad Prism (v6.0h). Differences were deemed to be 
significant if p ≤ 0.05. Data are expressed as means ± SEM. Tests included one-way or two-
way ANOVA and unpaired Student’s t tests. Data heterogenity was tested and, where 
variance was significant, appropriate non-parametric tests were used. Corrections for multiple 
comparisons were performed using appropriate post-hoc tests. Linear relationships between 
two variables were measured by Pearson’s correlation analysis. 
 
3 Results 
3.1.1 Spatial learning is impaired in aged APP/PS1 mice 
During the acquisition phase of the MWM, escape latency significantly decreased over time 
(p<0.0001), as expected, and was also significantly greater overall in APP/PS1 mice (Fig. 
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1A; p=0.0264). However, post-hoc analysis indicated that average escape latency was not 
significantly different between aged wild type and APP/PS1 mice on any of the training days 
(Fig. 1A). In the probe trial, time spent in each quadrant by wild type mice was not 
significantly different (Fig. 1D). Similarly, APP/PS1 mice spent a similar amount of time 
swimming in all 4 quadrants in the probe trial and although significant variation in the time 
spent in each quadrant was detected (p=0.0174), post-hoc analysis showed that time spent in 
the target quadrant by APP/PS1 mice was not significantly different from any other quadrant 
(Fig. 1G). In the acquisition phase of the RWM, escape latency decreased over time (Fig. 1B; 
p=0.0009) and was also significantly affected by genotype (Fig. 1B; p=0.0020). Post-hoc 
analysis revealed that average escape latency was significantly greater in APP/PS1 mice, 
compared to wild types on days 2 (p<0.05), 3 (p<0.01) and 4 (p<0.05; Fig. 1B).  
In the reversal probe trial, time spent in each of the quadrants by wild types (Fig. 1E) 
or APP/PS1 (Fig. 1H) mice did not differ significantly  
 
3.1.2 Recognition memory is impaired in aged APP/PS1 and wild type mice 
In the acquisition phase of the ORT, recognition indices for the identical objects were not 
significantly different in 15-18 month old APP/PS1 or wild type mice (Fig. 1C). In the test 
phase, recognition index for the novel object was not significantly different from the familiar 
in the aged APP/PS1 mice or the age-matched control group (Fig. 1F).  
 
 
 
3.1.3 Immunohistochemistry 
3.1.3.1 A deposition is ubiquitous in brains of aged APP/PS1 mice 
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Representative micrographs from wild type mice show that A immunopositivity was almost 
completely absent from the cortex (0.0054% ± 0.0012) and dentate gyrus (0.0178 ± 0.0136) 
(Fig. 2A and B). However, widespread A deposition was apparent in the cerebral cortex and 
dentate gyrus of APP/PS1 mice (Fig. 2E and F). Quantification confirmed that A 
immunopositivity was significantly higher in the cortex (Fig. 2D; p<0.0001) and dentate 
gyrus (Fig. 2H; p<0.0001) of APP/PS1 mice compared to wild type controls.  
 
3.1.3.2 IRS-1 pSer
616 
is elevated in brains of aged APP/PS1 mice 
Representative micrographs illustrate increased levels of IRS-1 pSer
616 
in the cerebral cortex 
(Fig. 2M) and dentate gyrus (Fig. 2N) of APP/PS1 mice, compared to age-matched wild 
types (Fig. 2I and J). Although distribution of IRS-1 pSer
616
 staining was similar between 
groups in both brain regions, staining intensity was greater in APP/PS1 mice (Fig. 2O) 
compared to wild types (Fig. 2K). As such, quantification showed that IRS-1 pSer
616 
was 
significantly greater in the cortex (Fig. 2L; p=0.0303) and dentate gyrus (Fig. 2P; p=0.0429) 
of aged APP/PS1 mice compared to wild type controls. Pearson’s correlation analysis 
identified negative correlations between recognition index for the novel object in ORT and  
 IRS-1 pSer
616 
immunopositivity in the cortex (Fig. 7A) dentate gyrus (Fig. 7B) of wild type 
and APP/PS1 mice. Although the negative correlation between cortical IRS-1 pSer
616
 staining 
and ORT recognition index in APP/PS1 approached significance (Fig. 7A; r=-0.7744, 
p=0.0706) the negative trends between IRS-1 pSer
616 
staining and ORT recognition index 
remained insignificant in both brain regions of both genotypes.  
 
3.1.3.3 Oxidative stress is comparable in brains of aged APP/PS1 and wild type mice 
Representative micrographs shown in Fig. 3A-C and E-G illustrate the similarity in oxidative 
stress levels between the brains of aged APP/PS1 mice and wild type controls. Quantitative 
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analysis demonstrated that 8-oxoguanine immunopositivity was not significantly different in 
the cortex (Fig. 3D) or the dentate gyrus (Fig. 3H) of APP/PS1 mice compared to age-
matched wild type controls. 
 
3.1.3.4 Astrocytes are elevated in brains of aged APP/PS1 mice 
Representative micrographs illustrate increased levels of GFAP-positive astrocytes in the 
cerebral cortex (Fig. 3I and J) and dentate gyrus (Fig. 3M and N) of aged APP/PS1 mice 
compared to wild type controls. Quantitative analysis revealed a significant increase in GFAP 
immunopositivity in the cortex (Fig. 3L; p=0.0010) and dentate gyrus (Fig. 3P; p=0.0007), 
compared to age-matched wild type mice. 
 
3.1.3.5 Synaptophysin is reduced in the polymorphic layer of the dentate gyrus of aged 
APP/PS1 mice 
Representative images illustrate reduced synaptophysin in the hippocampal polymorphic 
layer of 15-18 month old APP/PS1 mice (Fig. 4D) compared to wild types (Fig. 4A; 
p=0.0338). Synaptophysin staining was similar in all other layers of the hippocampus 
between wild type and APP/PS1 mice and was not significantly different in the granule cell 
(Fig. 4D), molecular layer (Fig. 4D), strata radiatum (Fig. 4E), pyramidale (Fig. 4E) or oriens 
(Fig. 4E) of APP/PS1 mice, compared to wild type controls (Fig. 4A and B). Furthermore, 
synaptophysin optical density did not differ significantly in the inner or outer (Fig. 4F) 
cortical layers of APP/PS1 mice, compared to age-matched wild types (Fig. 4C). 
Quantification confirmed that synaptophysin staining was reduced in the polymorphic layer 
of APP/PS1 mice, but was comparable with wild types in all other layers of the hippocampus 
and cortex (Fig. 4G). 
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3.1.4 Peripheral insulin sensitivity and glucose tolerance and inflammatory and insulin 
signaling gene expression in brains of aged APP/PS1 mice 
Expression of GLP-1R, IKK, ERK2, mTOR, NF-B1, PKCθ and TLR4 was comparable in 
brains of aged APP/PS1 and wild type mice and genotype did not have a significant effect on 
gene expression (Fig. 5A). Additional analysis comparing aged APP/PS1 mice with younger 
C57Bl/6 mice (17-22 weeks old) identified a significant effect of genotype on gene 
expression (Supplementary Fig. 1A; p<0.0001) and post-hoc analysis showed that expression 
of IKK (p<0.01), ERK2 (p<0.05) and mTOR (p<0.01) was significantly down-regulated 
and TLR4 (p<0.05) was up-regulated in brains of aged APP/PS1 mice, compared to young 
C57Bl/6 controls. As illustrated in Fig. 5C, in response to an insulin sensitivity test, a 
significant decrease in blood glucose over time was detected (p<0.0001), however genotype 
had no significant effect on blood glucose levels. Similarly, glucose tolerance was 
comparable in both groups and although time significantly affected blood glucose levels 
(p<0.0001), genotype was not associated with a change in peripheral glucose tolerance (Fig. 
5D). 
 
3.1.5 Cytokine levels in brains of aged APP/PS1 mice 
Brain levels of IFN (Fig. 6A; p=0.0046) and IL-4 (Fig. 6F; p=0.0013) were significantly 
elevated in brains of 15-18 month-old APP/PS1 mice compared to age-matched wild type 
mice (Fig. 6A). A trend towards elevated IL-1 was detected in the brains of APP/PS1 mice 
compared to age-matched wild types, however this failed to reach significance (Fig. 6C; 
p=0.0965). Additional analysis indicated that IL-1 was significantly elevated in the brains of 
15-18 month-old wild type (p<0.01) and APP/PS1 (p<0.0001) mice, compared to young wild 
types (Supplementary Fig. 1B). A significant increase in IL-4 (Supplementary Fig. 1C; 
p<0.001) and IFN (Supplementary Fig. 1D; p<0.01) was also detected in the brains of aged 
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APP/PS1 mice, compared to young wild type mice. In addition, Pearson’s correlation 
analysis identified a significant negative correlation between levels of IFN and novel object 
recognition index in APP/PS1 mice (Fig. 7C; r=-0.8362, p=0.0381), suggesting that higher 
levels of IFN in the brain were associated with worse ORT performance in APP/PS1 mice. 
No significant correlations were identified between IFN and IRS-1 pSer616 immunopositivity 
in the cortex or dentate gyrus (Fig. 7D and E). 
 
4. Discussion 
This study showed that peripheral glucose tolerance and insulin sensitivity were comparable 
between aged APP/PS1 and wild type mice, conflicting with a number of other studies (24, 
25). It has been suggested that 5/6 hours fasting is optimal for glucose and insulin tolerance 
tests, as this was sufficient for normalization of glucose levels and phosphorylation of insulin 
signaling proteins (26, 27). The current study performed glucose tolerance and insulin 
sensitivity tests following an overnight fasting period, so it is possible that results presented 
here reflect an exaggerated suppression of basal glucose levels in mice as a result of 
prolonged fasting. This suggestion is supported by Jimenez-Palomares et al. (28) who also 
found that glucose tolerance and insulin sensitivity were not significantly different in 8 
month-old APP/PS1 mice, compared to wild types following overnight fasting periods. 
Future studies should avoid overnight fasting prior to glucose and insulin tolerance tests in 
order to achieve optimal normalization of metabolic parameters and to avert potentially 
dangerous hypoglycemic effects of insulin. Other reports suggest that insulin insensitivity 
and glucose intolerance also exists in aged animals (29-31), including C57Bl/6 mice (32-34); 
a possible explanation for the similarity between APP/PS1 mice and controls in the present 
study. To better understand the impact of central insulin resistance on global insulin 
utilisation in the APP/PS1 model, future studies should assess the impact of hypothalamic 
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insulin administration alone and in combination with insulin sensitising drugs, such as 
metformin, in hyperinsulinemic euglycemic clamp models.  
Recognition memory was impaired in APP/PS1 mice here, consistent with several 
other studies (35-37). However, since wild type controls also exhibited impaired recognition 
memory, the deficits may be related to advanced age, rather than the APP/PS1 genotype; a 
suggestion supported by other studies reporting recognition memory deficits in aged C57Bl/6 
mice (38, 39). Another study found several indications of cognitive dysfunction in 18-20 
month-old C57Bl/6 mice, including impaired novel location memory, but not object 
recognition memory (40). Spatial learning was impaired in aged APP/PS1 mice, in agreement 
with other studies (41, 42). Spatial memory recall was impaired in APP/PS1 mice and wild 
type mice, similar to Barreto et al. (43), who showed that spatial learning and memory were 
impaired in 18 month-old C57Bl/6 mice. Other reports have highlighted age-related decline 
in learning and memory in C57Bl/6 mice (44, 45) consistent with the findings of the present 
study, providing further evidence that there exists age-related deterioration of cognitive 
function in C57Bl/6 mice. Learning in the reversal water maze task was impaired in aged 
APP/PS1 mice, compared to controls, while both APP/PS1 mice and wild types failed to 
recognize the reversal target quadrant. Some (46), but not others (47) have shown that 
reversal learning and memory are impaired in APP/PS1 mice. Results presented here, suggest 
that reversal learning is a cognitive domain that is especially vulnerable to the effects of AD 
pathology in aged mice.  
Amyloid- (A) deposits were detected throughout the brains of 15-18 month-old 
APP/PS1 mice, while A was undetectable in wild type controls. APP/PS1 mice develop 
plaque deposition by 6 months of age, which progressively worsens, leading to abundant and 
widespread A plaque pathology by the age of 14 months (48, 49). The finding that A 
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deposition was significant in APP/PS1 brains and absent from wild types suggests that the 
spatial memory deficits in both groups were not directly related to A burden. 
Oxidative stress levels were similar between APP/PS1 and wild type mice in the 
cortex and dentate gyrus. This was unexpected given previous reports showing elevated 
oxidative damage in brains of aged APP/PS1 mice (50-52). However, since aging is 
associated with accumulation of oxidative stress in the brain (53, 54), results presented here 
may reflect age-related accumulation of oxidative DNA damage in both APP/PS1 and wild 
type mice.  
IRS-1 pSer
616 
was increased in brains of APP/PS1 mice, as has also been observed in 
AD patients (18, 19, 55) and in experimental models (55, 56). The findings of the present 
study corroborate those of Talbot et al. (18) that demonstrated elevated IRS-1 pSer
616 
in the 
hippocampus of APP/PS1 mice. IRS-1 pSer
616 
has been shown to robustly correlate with 
cognitive impairment and brain insulin resistance associated with AD (18) and is likely 
related to the cognitive impairment in APP/PS1 mice here. It is interesting to note that the 
increased brain insulin resistance in aged APP/PS1 mice was apparent in the absence of any 
significant indications of peripheral insulin insensitivity or glucose intolerance. 
Astrocytes were increased in the cortex and dentate gyrus of APP/PS1 mice, 
consistent with previous reports (50, 57). Neuroinflammation and glial cell proliferation, 
recruitment and activation is a commonly associated with AD pathology (13). The fact that 
A deposition remained substantial in the brains of APP/PS1 mice suggests that clearance of 
A was minimal, providing support for the proposal that astrocyte function is defective in 
AD (58). Expression of inflammatory and insulin signaling genes was similar in brains of 
aged APP/PS1 mice and age-matched wild type controls. It has been shown previously that 
expression of TLR4 is up-regulated in brains of APP/PS1 and wild type mice in an age-
related manner (59) and the present report provides further evidence that TLR4 expression in 
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brain is increased with normal aging, to levels comparable with APP/PS1 mice. Th1 cytokine 
IFN was elevated in brains of APP/PS1 mice compared to wild types, in agreement with 
another study that showed age-related enhancement of IFN in brains of AD mice from 3 to 
19 months of age (60). It has also been shown that IFN has opposing functions in AD brain, 
whereby overexpression of IFN in the hippocampus augments neuroinflammation and 
worsens A burden, but abrogates tau pathology and enhances synaptic markers and 
neurogenesis (61). Further experimentation should determine whether the increased IFN in 
brains of APP/PS1 mice here represents a component of pathogenic neuroinflammation or an 
up-regulation of protective processes. A significant negative correlation was identified here 
between IFN levels and novel object recognition memory in APP/PS1 mice, in line with a 
recent study demonstrating improved hippocampal synaptic plasticity and cognitive 
performance in mice deficient for IFN (62), suggesting that increased IFN in the brain may 
impair cognitive function in aged APP/PS1 mice. The increase in IFN is mirrored by a 
comparable increase in anti-inflammatory IL-4 in brains of APP/PS1 mice, which likely 
reflects an attempt to suppress the Th1 response.  Interestingly IFN has also been implicated 
in attenuation of insulin signaling (63) and may be similarly associated with the brain insulin 
resistance in the present study. Although we failed to detect significant correlations between 
brain levels of IFN and IRS-1 pSer616, this potential mechanism certainly warrants further 
exploration.  
Previous studies have detected increased IL-1 in the brains of APP/PS1 mice (64, 
65). The present report, however, detected a non-significant trend towards an increase in IL-
1 in the brains of APP/PS1 mice, possibly due to a parallel, age-related elevation of IL-1 in 
wild-type mice. This suggests that IL-1 is involved with neuroinflammation that 
accompanies normal aging, while IFN and IL-4 are not part of the normal process of aging, 
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but are components of the neuroinflammatory processes associated with AD, since these were 
elevated in aged APP/PS1 mice, compared to both young and old wild types. 
Expression of mTOR and ERK2 was comparable in brains of aged APP/PS1 mice, 
compared to wild types. Extracellular signal-regulated kinase 2 (ERK2) signaling facilitates 
learning and memory (68, 69), suggesting that impaired cognitive function in aged mice may 
be due, in part to reduced expression of ERK2 in the brain. Dineley et al. (70) showed that 
A reduces ERK2 activity and that ERK2 expression is down-regulated in brains of 20 
month-old AD mice. Similarly, dysregulation of signaling downstream of mTOR has been 
demonstrated in post-mortem brain tissue from AD patients (71). Signaling through mTOR 
contributes to synaptic plasticity, learning and memory (72, 73). It has also been shown that 
insulin promotes neurogenesis, dendrite and synapse formation by signaling through IRS-
mediated activation of mTOR (74, 75). Amyloid- (A) perturbs mTOR signaling in neurons 
(76) and mTOR inhibition impairs hippocampal LTP in an AD mouse model (77). Our results 
suggest that expression of insulin signaling components is comparable in aged APP/PS1 and 
wild-type mice. Disruption of insulin signaling in the brain may be involved in the 
pathophysiology of AD and may contribute to cognitive impairments associated with aging, a 
proposition that should be further probed in future studies.  
Synaptophysin staining was reduced in the polymorphic layer of the dentate gyrus of 
APP/PS1 mice. Several previous studies have shown that synapse density is decreased in the 
brains of APP/PS1 mice (78-80). These studies did not consider the discrete cellular layers of 
the hippocampus and may have overlooked subtle variation in synapse density between 
subregions (78-80). However, one report showed that synaptophysin levels in the 
hippocampus of 7 and 17 month-old APP/PS1 mice were similar to age-matched wild types 
(81), which more closely aligns with the findings of the present study. It has also been shown 
in Tg2576 mice, that synaptophysin levels were no different from controls at 3, 9, 14 and 19 
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months of age (82), while Xu et al. (45) reported age-related decline in hippocampal synaptic 
spine density in C57Bl/6 mice. Results of the present report reflect a similar pattern, with 
synapse density being comparable to wild types in 15-18 month-old APP/PS1 mice. Since 
synapse density in the polymorphic layer was reduced in aged transgenic mice, it is 
reasonable to suggest that this subregion was selectively susceptible to synaptotoxicity 
associated with AD neuropathology.  
A limitation of the present study is the absence of young cohorts of wild type and 
APP/PS1 mice. Based on evidence from the literature, it is likely that peripheral insulin 
sensitivity, cognitive function and synapse density were influenced by aging. Future studies 
should include groups of young wild type and transgenic mice in order to more robustly 
characterize the differences between AD pathology and changes associated with normal 
aging, throughout the lifecourse. Another limitation of the present report is that cytokines and 
mRNA were measured in whole hemi-brains, while analysis of immunohistochemistry was 
performed on brain sections allowing for quantification within discrete brain regions. This 
means that comparing the results of our biochemical assays with our immunohistochemical 
data is difficult. Future studies will analyse mRNA and associated proteins and activation 
states in discrete brain regions to allow for more accurate demarcation of differences between 
APP/PS1 mice and wild types with regard to insulin signaling dysregulation and 
inflammation the brain.  
 Nevertheless, this study has demonstrated memory deficits and neuroinflammation in 
aged APP/PS1 and wild type mice. Astrocyte accumulation, IL-1 and IRS-1 pSer616 levels 
were increased in the brain of APP/PS1 mice in the absence of systemic insulin insensitivity 
or glucose intolerance. Pharmacological agents targeting impaired insulin signaling and 
inflammation in the brain may prove efficacious in treating AD, a suggestion requiring 
further investigation. 
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Figure Legends 
Figure 1. Learning and memory in aged APP/PS1 and wild type mice. The acquisition 
training phase of the Morris water maze (MWM) involved four training sessions per day 
over four consecutive days, followed by a probe trial on the fifth day, 24 hours following the 
final training session. Escape latency during the training phase is shown (A), as is the 
proportion of time spent in each quadrant during the probe trial by 15-18 month-old wild 
type (solid line with circles; D) and APP/PS1 (dotted line with squares; G) mice. Reversal 
water maze acquisition training began 24 hours following the MWM probe trial and 
consisted of four consecutive days with four training sessions per day, followed by a reversal 
probe trial on the fifth day. Illustrated are training phase escape latency (B) and time spent in 
each quadrant during the reversal probe trial by wild type (E) and APP/PS1 (H) mice. For 
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the novel object recognition task, recognition index, a measure of the percentage of time 
spent exploring either object, is illustrated in the acquisition phase (C) during exposure to 
two identical objects, and the test phase (F), in the presence of one familiar (black bars) and 
one novel (white bars) object. *p<0.05, **p<0.01 APP/PS1 vs. wild type; two-way repeated 
measures ANOVA with Bonferroni’s post-hoc test (A, B), ordinary one-way ANOVA with 
Dunnett’s post-hoc test (D, E, G, H), multiple t tests with Holm-Šídák’s post-hoc test (C, F). 
Data represent mean ± SEM for 13-15 mice per group. 
 
Figure 2. A deposition and IRS-1 pSer616 in the cerebral cortex and dentate gyrus of 
aged APP/PS1 and wild type mice. Representative images (10x magnification) are shown 
that depict A staining in the cerebral cortex (A) and dentate gyrus (B) of 15-18 month old 
wild type mice and the cerebral cortex (E) and dentate gyrus (F) of age-matched APP/PS1 
mice. Also shown is an exemplary magnified image (20x magnification) of A staining in 
brains of wild type (C) and APP/PS1 (G) mice. Quantification of A immunopositivity in 
the cortex (D) and dentate gyrus (H) of 15-18 month old APP/PS1 and wild type mice is also 
shown. Representative images (20x magnification) are also shown that depict IRS-1 pSer
616 
staining in the cerebral cortex (I) and dentate gyrus (J) of 15-18 month old wild type mice 
and the cerebral cortex (M) and dentate gyrus (N) of age-matched APP/PS1 mice. Also 
shown are exemplary magnified images (40x magnification) from wild type (K) and 
APP/PS1 (O) mice. Quantification of IRS-1 pSer
616
 immunopositivity in cortex (L) and 
dentate gyrus (P) of 15-18 month old APP/PS1 and wild type mice is also illustrated. 
*p<0.05, ****p<0.0001, Student’s t test. Data represent mean ± SEM for 6 per group. 
 
Figure 3. Oxidative stress and astrocytes in the cerebral cortex and dentate gyrus of 
aged APP/PS1 and wild type mice. Representative images (20x magnification) are shown 
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that depict the 8-oxoguanine staining in cerebral cortex (A) and dentate gyrus (B) of 15-18 
month old wild type mice and cerebral cortex (E) and dentate gyrus (F) of age-matched 
APP/PS1 mice. Also shown are exemplary magnified images (40x magnification) from wild 
type (C) and APP/PS1 (G) mice. Quantification of 8-oxoguanine immunopositivity in cortex 
(D) and dentate gyrus (H) of 15-18 month old APP/PS1 and wild type mice is also 
illustrated. Representative images (20x magnification) are also shown that depict GFAP 
staining in the cerebral cortex (I) and dentate gyrus (J) of 15-18 month-old wild type mice 
and the cerebral cortex (M) and dentate gyrus (N) of age-matched APP/PS1 mice. Also 
shown are exemplary magnified images (100x magnification) from wild type (K) and 
APP/PS1 (O) mice. Quantification of GFAP immunopositivity in cortex (L) and dentate 
gyrus (P) of 15-18 month old APP/PS1 and wild type mice is also shown. ***p<0.001; 
Student’s t test. Data represent mean ± SEM for 6 per group. 
 
Figure 4. Synapse density is decreased in the polymorphic layer of the dentate gyrus in 
APP/PS1 mice. Illustrated are representative images depicting synaptophysin staining of 
brain sections from 15-18 month-old wild type (A, B, C) and APP/PS1 (D, E, F) mice. A 
and D show the polymorphic layer (PL), granule cell layer (GCL) and molecular layer (ML) 
of the dentate gyrus. C and D show the stratum radiatum (SR), stratum pyramidale (SP) and 
stratum oriens (SO) of the hippocampus, while B and E show the inner (IC) and outer (OC) 
cerebral cortex. Also illustrated is quantification of synaptophysin optical density values for 
the polymorphic layer, granule cell layer and molecular layer of the dentate gyrus and the 
stratum radiatum, stratum pyramidale and stratum oriens of the hippocampus, inner and outer 
cortex of 15-18 month-old APP/PS1 and wild type mice (G). *p<0.05; Student’s t tests. Data 
represent mean ± SEM for 6 per group. 
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Figure 5. Peripheral insulin sensitivity, glucose tolerance and expression of 
inflammatory and insulin signaling genes in brains of aged APP/PS1 mice. Illustrated is 
quantification of the expression of genes associated with inflammatory pathways and insulin 
signaling in brains of 15-18 month-old APP/PS1 mice (black bars), compared with age-
matched wild type controls (white bars) (A). Also shown are blood glucose levels following 
insulin injection (B) and following glucose injection (C). Wild type (solid line with circles) 
and APP/PS1 mice (dotted line with squares) aged 15-18 months were administered insulin 
or glucose via i.p. injection and blood glucose levels were measured at 15, 30 and 60 minutes 
post-injection. *p<0.05, **p<0.01; ordinary two-way ANOVA with Holm-Šídák’s post-hoc 
test (A) or 13-15 per group, two-way repeated measures ANOVA with Holm-Šídák’s post-
hoc test (B, C). Data represent mean ± SEM for 5 per group. 
 
Figure 6. Cytokine levels in the brains of aged APP/PS1 and wild type mice. MSD 
multiplex analysis of 8 cytokines was performed on supernatant extracted from brain tissue. 
Protein levels of IFN (A), IL-10 (B), IL-1 (C), IL-12p70 (D), IL-2 (E), IL-4 (F), IL-5 (E), 
IL-6 (G) and KC/GRO (CXCL1) (H) were measured and compared between 15-18 month-
old APP/PS1 mice (black bars) and age-matched wild types (white bars).**p<0.01; Student’s 
t tests. Data represent mean ± SEM for 6 per group.. 
 
Figure 7. Correlations between IFN, IRS-1 pSer616 and novel object recognition 
memory in aged APP/PS1 and wild type mice. Pearson’s correlation analysis was 
performed between IRS-1 pSer
616 
immunopositivity and novel object recognition index (A, 
B), between IFN and novel object recognition index (C) and between IFN and IRS-1 
pSer
616 
immunopositivity (D, E) in wild type (open circles and dotted best fit line) and 
APP/PS1 (black squares and solid best fit line) mice. Lines of best fit, r and p values were 
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also added to the graphs. Each data point represents an XY pair for a total of 6 XY pairs per 
genotype on each graph. Significance of correlation was determined using two-tailed t tests. 
 
Supplementary Figure 1. Cytokines and gene expression in brains of young wild type 
mice. Quantification of expression of inflammatory and insulin signaling genes in the brains 
of young wild type mice (17-22 weeks old) is shown (black bars), compared to aged wild 
types (white bars) and APP/PS1 mice (dark grey bars) (A). Also illustrated are brain levels of 
IFN (B), IL-1 (C) and IL-4 (D) in young wild type mice, compared with aged wild types 
and APP/PS1 mice. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; ordinary one-way 
ANOVA with Holm-Šídák’s post-hoc test (A) and Student’s t test (B-D). Data represent 
mean ± SEM for 5 (A) or 6 (B-D) per group. 
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Abstract 
Cognitive dysfunction and neuroinflammation are typical in Alzheimer’s disease (AD), but 
are also associated with normal aging, albeit less severely. Insulin resistance in the brain has 
been demonstrated in AD patients and is thought to be involved in AD pathophysiology. 
Using 15-18 month-old APP/PS1 mice, this study measured peripheral and central insulin 
signaling and sensitivity, inflammatory markers in brain and plasma and oxidative stress and 
synapse density in the brain. Novel object recognition, Morris water maze and reversal water 
maze tasks were performed to assess cognitive function in aged APP/PS1 mice and wild type 
littermates. Glucose tolerance and insulin sensitivity were similar in APP/PS1 mice and wild 
type controls, however IRS-1 pSer
616
 was increased in cortex and dentate gyrus of APP/PS1 
mice. Recognition and spatial memory was impaired in both APP/PS1 and wild type mice, 
however learning impairments were apparent in APP/PS1 mice. Expression of GLP-1 
receptor, ERK2, IKK, mTOR, PKCθ, NF-B1 and TLR4 was similar between aged 
APP/PS1 mice and age-matched wild types, however, compared to young wild types (7-9 
month-old), IKK, mTOR and ERK2 were decreased in brains of APP/PS1 mice, while 
TLR4 expression was increased.. Compared to age-matched and younger wild type mice, 
IFN and IL-4 were increased in brains of APP/PS1 mice, whereas IL-1 was increased in 
the brains of aged wild type and APP/PS1 mice, compared to young controls. . These results 
suggest that normal aging may beis associated with enhanced neuroinflammation, oxidative 
stress, and cognitive decline, however distinctions are apparent in the brain of APP/PS1 mice 
in terms of inflammation and insulin signaling and in certain cognitive domains. Demarcation 
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of pathological events that distinguish AD from normal aging will allow for improvements in 
diagnostic tools and the development of more effective therapeutics.  
 
Keywords: Alzheimer’s disease; aging; neuroinflammation; insulin signaling; cognitive 
function; learning; memory; insulin sensitivity; cytokines 
 
Abbreviations: A Amyloid- AD Alzheimer’s disease ERK2 extracellular signal-regulated 
kinase 2 IKK Inhibitor of NF-B kinase  IRS-1 pSer616 Insulin receptor substrate-1 
phosphorylated at serine residue 616 MAPK mitogen-activated protein kinase mTOR 
mechanistic target of rapamycin MWM Morris water maze ORT Novel object recognition 
task PKC Protein kinase C RI Recognition index RWM Reversal water maze TLR4 Toll-
like receptor 4 
 
1 Introduction 
As healthcare improves around the world, life expectancy continues to rise (1). Accordingly, 
the past 25 years have seen a dramatic increase in disorders associated with aging, including 
neurological diseases such as Alzheimer’s disease (AD) (1), for which advancing age is the 
principal risk factor (2).  
Many clinical and neuropathological features of AD parallel the normal progression 
of aging, making differentiation between normal brain aging and early-stage AD difficult. 
Generally, it can be said that healthy aging is associated with moderate decline in some 
cognitive abilities, whilst AD is characterized by severe deterioration of the same cognitive 
domains, with additional progressive decline of further cognitive functions, such that the 
patient’s daily life is adversely affected to a severe degree (3). In AD, amyloid- (A) 
accumulates into progressively larger fibrils, which become deposited as insoluble plaques in 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
the brain parenchyma (4). Accumulating evidence suggests that the presence of A fibrils 
and plaques is not uncommon in the brains of non-demented, cognitively healthy older 
people (5, 6). Several studies have also shown that A deposition does not correlate with 
cognitive impairment in elderly cohorts (6), highlighting the variability of age-related 
cognitive decline and suggesting that A per se does not directly influence cognitive 
function.  
Profound inflammation is evident in AD brain (7), primarily mediated by microglia 
and astrocytes (8, 9). Activated microglia and astrocytes phagocytose A oligomers and 
fibrils, degrade A plaques and reduce amyloid burden (10, 11). However, sustained 
microglial activation and unresolved inflammation in the brain is harmful to neurons and 
synapses and promotes chronic dysregulation of glial cells and subsequent deterioration of 
brain structure and function (12, 13). Inflammation in the brain increases with age (14) and 
several studies have shown elevated levels of inflammatory cytokines in the brains of aged 
rodents (15, 16). In the context of AD, primed microglia respond more readily to A, 
producing increased levels of cytokines that exert direct toxic effects on neurons and at 
synapses (17).  
Insulin resistance has been demonstrated in postmortem brain tissue from AD patients 
and those with mild cognitive impairment, in the absence of diabetes and irrespective of 
ApoE-ε4 status (18). Furthermore, IRS-1 pSer616 was identified as a putative biomarker of 
brain insulin resistance in AD and was found to correlate positively with A oligomer levels 
and negatively with cognitive function (18). Additionally, Bomfim et al. (19) demonstrated 
increased levels of IRS-1 pSer
616 
in the hippocampus of 13 month-old APP/PS1 mice. Other 
studies have also demonstrated impaired neuronal insulin signaling in AD brain and in 
response to A oligomer challenge (20, 21). 
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This study sought to determine differences in learning and memory, oxidative stress, 
glucose tolerance, central and peripheral insulin sensitivity between 15-18 month old wild 
type and age-matched APP/PS1 mice. Using novel object recognition and Morris water maze 
tasks, cognitive function was measured in aged wild type and APP/PS1 mice. Systemic 
insulin sensitivity and glucose tolerance were compared between groups. Brain levels of A, 
GFAP, 8-oxoguanine, IRS-1 pSer
616
 and synaptophysin were measured by 
immunohistochemistry. Additionally inflammatory and insulin signaling associated genes, 
GLP-1R, IKK, ERK2, mTOR, NF-B1, PKCθ, and TLR4 and inflammatory cytokines 
(IFN, IL-10, IL-1, IL-12p70, IL-2, IL-4, IL-5, IL-6 and KC/GRO (CXCL1)) were assessed 
in brain tissue from aged APP/PS1 and wild type mice to delineate pathological changes from 
those associated with ‘normal’ aging. 
 
 
 
 
 
2 Materials and Methods 
2.1.1 Animals 
Male APPswe/PS1Δe9 (APP/PS1) mice with a C57Bl/6J background were bred with wild type 
C57Bl/6J females at the Biomedical and Behavioural Research Unit at Ulster University in 
Coleraine. Offspring were ear punched and positivity for the APPswe/PS1Δe9 transgene, or 
lack thereof was confirmed by polymerase chain reaction, using primers specific for the APP 
sequence of the APP/PS1 construct (Forward “GAATTCCGACATGACTCAGG”, Reverse: 
“GTTCTGCTGCATCTTGGACA”). Offspring males heterozygous for the APPswe/PS1Δe9 
transgenic construct were then age-matched with wild type littermates, not expressing the 
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transgene, which were used as controls. Both groups of mice were caged individually and 
allowed access to food and water ad libitum. Animals were maintained on a 12:12 light-dark 
cycle (lights on at 08:00, lights off at 20:00), within a temperature-controlled room (T: 
21.5°C ± 1°C). All tests were performed during the light cycle. All experiments were 
designed, analyzed and reported in accordance with ARRIVE guidelines. Experiments were 
licensed according to UK Home Office regulations (UK Animals Scientific Procedures Act 
1986) and associated guidelines (EU Directive 2010/63/EU). C57Bl/6 mice were derived 
from a colony maintained in the Biomedical and Behavioural Research Unit at Ulster 
University in Coleraine.  
 
2.1.2 Glucose tolerance and insulin sensitivity tests 
After an overnight fasting period, APP/PS1 mice and age-matched wild types received an i.p. 
injection of glucose (18 mmol/kg bw) in 0.9% NaCl or insulin (0.25 M/g). Blood glucose 
was measured at 0, 15, 30 and 60 minutes following glucose or insulin injection using a 
hand-held Ascencia Contour blood glucose meter (Bayer Health Care).  
 
2.1.3 Behavioural Assessment 
Mice were assessed in the ORT, as described previously (22). Briefly, mice were subjected to 
a 10 minute acquisition period, with two identical objects, followed by a 3 hour retention 
period and a 10 minute test phase, which involved replacing one of the objects with a novel 
object. A recognition index (RI) was calculated for each object, defined as amount of time 
spent exploring object A or B over the total time spent exploring both objects x 100 (tA or 
tB/(tA + tB) x 100).  
Following ORT, mice were assessed in the Morris water maze (MWM) (22). The 
acquisition training phase consisted of 4 x 90 second trials per day, for 4 consecutive days, 
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followed by a probe trial on the fifth day. The day after the probe trial, mice were subjected 
to reversal water maze (RWM), wherein the escape platform was moved from the southwest 
to northwest quadrant. There were 4 trials per day, for 4 consecutive days, followed by a 
reversal probe trial on day 5. 
 
2.1.4 Immunohistochemistry 
Following sacrifice, animals were perfused with PBS and brains excised. One hemisphere 
was fixed in 4% paraformaldehyde and the other was frozen in liquid nitrogen. Hemi-brains 
for histology were then transferred to 30% sucrose and 40 m coronal sections were cut 
using a cryostat (Leica Microsystems). One section in every 6 was collected sequentially and 
stored at -20C. Staining was performed for A, GFAP, 8-oxoguanine, IRS-1 pSer616 and 
synaptophysin. All sections were incubated in H2O2  and permeabilized using Triton X. For 8-
oxoguanine, sections were incubated at 37°C for 30 minutes with 2 M hydrochloric acid, 
followed by 0.1 M borax (Sigma Aldrich) for 10 minutes. Blocking with 1.5%-10% normal 
serum was performed prior to incubation with anti-A (1:200; Invitrogen; 71-5800) anti-
GFAP (1:250; Merck Millipore; MAB3402), anti-8-oxoguanine (1:250; Merck Millipore; 
MAB3560), anti-IRS-1 pSer
616
 (1:200; Invitrogen; 44-550G) or anti-synaptophysin (1:200; 
Abcam; ab7837) antibodies overnight at 4°C. Sections were then incubated with secondary 
antibodies and visualized using Vectastain Elite and SG substrate (Vector Laboratories). 
Percentage area stained in each image was quantified using a multi threshold plug-in within 
Image J (NIH, Bethesda, USA) in a blinded manner. 
 
 
2.1.5 Quantitative polymerase chain reaction (qPCR) 
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RNA was extracted from brain tissue using RNeasy Lipid Tissue Mini Kit (Qiagen) 
according to manufacturer’s instructions. For cDNA synthesis, transcriptor First Strand 
cDNA synthesis kit (Roche Diagnostics) was used using 500 ng of RNA per sample. Real-
time PCR reactions were composed of; 5 μl of PCR MasterMix (Roche Diagnostics), 1 μl (10 
pM/l) gene-specific probes, 3 μl of RNase free water and 1 μl (25ng) of template cDNA. 
Gene-specific probes (Roche Diagnostics) were as follows: GLP-1R (Glp1r), IKK (Ikbkb), 
ERK2 (Mapk1), mTOR (Mtor), NF-B1 (Nfkb1), PKCθ (Prkcq) and TLR4 (Tlr4). 
Quantitative PCR was performed on Lightcycler 480 system (Roche Diagnostics), and 
quantified on accompanying software package (Roche, Lightcycler 480 software, v1.5). Gene 
expression changes were calculated using Delta Delta CT mathematical model (23). 
 
2.1.6 Meso Scale Discovery multi-array 
Whole hemi-brains were homogenized under liquid nitrogen, followed by addition of 10 ml/g 
of lysis buffer (1 mM EDTA in PBS supplemented with protease inhibitor cocktail). Samples 
were centrifuged at 14,000 G for 20 min at 4°C and supernatant was removed and added to 
Meso Scale Discovery (MSD
®
) plate. Bradford protein assay was performed to measure 
protein content and data were normalized to the total amount of protein present in each 
sample. Levels of IFN, IL1, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, TNF- and KC/GRO 
(CXCL1) were quantified in brain and plasma using MSD
®
 Multi-spot Assay Pro-
inflammatory panel 1 kit (Rockville, MD, USA) according to manufacturer’s instructions.  
 
2.1.7 Statistical Analysis 
Data were analyzed using Graphpad Prism (v6.0h). Differences were deemed to be 
significant if p ≤ 0.05. Data are expressed as means ± SEM. Tests included one-way or two-
way ANOVA and unpaired Student’s t tests. Data heterogenity was tested and, where 
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variance was significant, appropriate non-parametric tests were used. Corrections for multiple 
comparisons were performed using appropriate post-hoc tests. Linear relationships between 
two variables were measured by Pearson’s correlation analysis. 
 
3 Results 
3.1.1 Spatial learning is impaired in aged APP/PS1 mice 
During the acquisition phase of the MWM, escape latency significantly decreased over time 
(p<0.0001), as expected, and was also significantly greater overall in APP/PS1 mice (Fig. 
1A; p=0.0264). However, post-hoc analysis indicated that average escape latency was not 
significantly different between aged wild type and APP/PS1 mice on any of the training days 
(Fig. 1A). In the probe trial, time spent in each quadrant by wild type mice was not 
significantly different (Fig. 1D). Similarly, APP/PS1 mice spent a similar amount of time 
swimming in all 4 quadrants in the probe trial and although significant variation in the time 
spent in each quadrant was detected (p=0.0174), post-hoc analysis showed that time spent in 
the target quadrant by APP/PS1 mice was not significantly different from any other quadrant 
(Fig. 1G). In the acquisition phase of the RWM, escape latency decreased over time (Fig. 1B; 
p=0.0009) and was also significantly affected by genotype (Fig. 1B; p=0.0020). Post-hoc 
analysis revealed that average escape latency was significantly greater in APP/PS1 mice, 
compared to wild types on days 2 (p<0.05), 3 (p<0.01) and 4 (p<0.05; Fig. 1B).  
In the reversal probe trial, time spent in each of the quadrants by wild types (Fig. 1E) 
or APP/PS1 (Fig. 1H) mice did not differ significantly  
 
3.1.2 Recognition memory is impaired in aged APP/PS1 and wild type mice 
In the acquisition phase of the ORT, recognition indices for the identical objects were not 
significantly different in 15-18 month old APP/PS1 or wild type mice (Fig. 1C). In the test 
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phase, recognition index for the novel object was not significantly different from the familiar 
in the aged APP/PS1 mice or the age-matched control group (Fig. 1F).  
 
 
 
3.1.3 Immunohistochemistry 
3.1.3.1 A deposition is ubiquitous in brains of aged APP/PS1 mice 
Representative micrographs from wild type mice show that A immunopositivity was almost 
completely absent from the cortex (0.0054% ± 0.0012) and dentate gyrus (0.0178 ± 0.0136) 
(Fig. 2A and B). However, widespread A deposition was apparent in the cerebral cortex and 
dentate gyrus of APP/PS1 mice (Fig. 2E and F). Quantification confirmed that A 
immunopositivity was significantly higher in the cortex (Fig. 2D; p<0.0001) and dentate 
gyrus (Fig. 2H; p<0.0001) of APP/PS1 mice compared to wild type controls.  
 
3.1.3.2 IRS-1 pSer
616 
is elevated in brains of aged APP/PS1 mice 
Representative micrographs illustrate increased levels of IRS-1 pSer
616 
in the cerebral cortex 
(Fig. 2M) and dentate gyrus (Fig. 2N) of APP/PS1 mice, compared to age-matched wild 
types (Fig. 2I and J). Although distribution of IRS-1 pSer
616
 staining was similar between 
groups in both brain regions, staining intensity was greater in APP/PS1 mice (Fig. 2O) 
compared to wild types (Fig. 2K). As such, quantification showed that IRS-1 pSer
616 
was 
significantly greater in the cortex (Fig. 2L; p=0.0303) and dentate gyrus (Fig. 2P; p=0.0429) 
of aged APP/PS1 mice compared to wild type controls. Pearson’s correlation analysis 
identified negative correlations between recognition index for the novel object in ORT and  
 IRS-1 pSer
616 
immunopositivity in the cortex (Fig. 7A) dentate gyrus (Fig. 7B) of wild type 
and APP/PS1 mice. Although the negative correlation between cortical IRS-1 pSer
616
 staining 
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and ORT recognition index in APP/PS1 approached significance (Fig. 7A; r=-0.7744, 
p=0.0706) the negative trends between IRS-1 pSer
616 
staining and ORT recognition index 
remained insignificant in both brain regions of both genotypes.  
 
3.1.3.3 Oxidative stress is comparable in brains of aged APP/PS1 and wild type mice 
Representative micrographs shown in Fig. 3A-C and E-G illustrate the similarity in oxidative 
stress levels between the brains of aged APP/PS1 mice and wild type controls. Quantitative 
analysis demonstrated that 8-oxoguanine immunopositivity was not significantly different in 
the cortex (Fig. 3D) or the dentate gyrus (Fig. 3H) of APP/PS1 mice compared to age-
matched wild type controls. 
 
3.1.3.4 Astrocytes are elevated in brains of aged APP/PS1 mice 
Representative micrographs illustrate increased levels of GFAP-positive astrocytes in the 
cerebral cortex (Fig. 3I and J) and dentate gyrus (Fig. 3M and N) of aged APP/PS1 mice 
compared to wild type controls. Quantitative analysis revealed a significant increase in GFAP 
immunopositivity in the cortex (Fig. 3L; p=0.0010) and dentate gyrus (Fig. 3P; p=0.0007), 
compared to age-matched wild type mice. 
 
3.1.3.5 Synaptophysin is reduced in the polymorphic layer of the dentate gyrus of aged 
APP/PS1 mice 
Representative images illustrate reduced synaptophysin in the hippocampal polymorphic 
layer of 15-18 month old APP/PS1 mice (Fig. 4D) compared to wild types (Fig. 4A; 
p=0.0338). Synaptophysin staining was similar in all other layers of the hippocampus 
between wild type and APP/PS1 mice and was not significantly different in the granule cell 
(Fig. 4D), molecular layer (Fig. 4D), strata radiatum (Fig. 4E), pyramidale (Fig. 4E) or oriens 
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(Fig. 4E) of APP/PS1 mice, compared to wild type controls (Fig. 4A and B). Furthermore, 
synaptophysin optical density did not differ significantly in the inner or outer (Fig. 4F) 
cortical layers of APP/PS1 mice, compared to age-matched wild types (Fig. 4C). 
Quantification confirmed that synaptophysin staining was reduced in the polymorphic layer 
of APP/PS1 mice, but was comparable with wild types in all other layers of the hippocampus 
and cortex (Fig. 4G). 
 
3.1.4 Peripheral insulin sensitivity and glucose tolerance and inflammatory and insulin 
signaling gene expression in brains of aged APP/PS1 mice 
Expression of GLP-1R, IKK, ERK2, mTOR, NF-B1, PKCθ and TLR4 was comparable in 
brains of aged APP/PS1 and wild type mice and genotype did not have a significant effect on 
gene expression (Fig. 5A). Additional analysis comparing aged APP/PS1 mice with younger 
C57Bl/6 mice (17-22 weeks old) identified a significant effect of genotype on gene 
expression (Supplementary Fig. 1A; Fig. 5B; p<0.0001) and post-hoc analysis showed that 
expression of IKK (p<0.01), ERK2 (p<0.05) and mTOR (p<0.01) was significantly down-
regulated and TLR4 (p<0.05) was up-regulated in brains of aged APP/PS1 mice, compared to 
young C57Bl/6 controls. As illustrated in Fig. 5C, in response to an insulin sensitivity test, a 
significant decrease in blood glucose over time was detected (p<0.0001), however genotype 
had no significant effect on blood glucose levels. Similarly, glucose tolerance was 
comparable in both groups and although time significantly affected blood glucose levels 
(p<0.0001), genotype was not associated with a change in peripheral glucose tolerance (Fig. 
5D). 
 
3.1.5 Cytokine levels in brains of aged APP/PS1 mice 
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Brain levels of IFN (p=0.0015Fig. 6A; p=0.0046), IL-1 (p<0.0001) and IL-4 (p=0.0002Fig. 
6F; p=0.0013) were significantly impacted by genotype (Fig. 6A, C and F). Post-hoc analysis 
revealed that IFN was significantly elevated in brains of 15-18 month-old APP/PS1 mice 
compared to age-matched (p<0.01) and young (p<0.01) wild type mice (Fig. 6A). A trend 
towards elevated IL-1 was comparable detected in the brains of APP/PS1 mice and 
compared to age-matched wild types, however a significant increase in IL-1 protein was 
detected in the brains of APP/PS1 mice, compared to 17-22 week-old wild type micethis 
failed to reach significance (Fig. 6C; p=<0.0965001). FurthermoreAdditional analysis 
indicated that, IL-1 was significantly elevated in the brains of 15-18 month-old wild type 
(p<0.01) and APP/PS1 (p<0.0001) mice, compared to young wild types (Supplementary Fig. 
1B) (Fig. 6C; p<0.01). A significant increase in IL-4 (Supplementary Fig. 1C; p<0.001) and 
IFN (Supplementary Fig. 1D; p<0.01) was also detected in the brains of aged APP/PS1 
mice, compared to age-matched (p<0.001) and young (p<0.001) wild type mice (Fig. 6F). In 
addition, Pearson’s correlation analysis identified a significant negative correlation between 
levels of IFN and novel object recognition index in APP/PS1 mice (Fig. 7C; r=-0.8362, 
p=0.0381), suggesting that higher levels of IFN in the brain were associated with worse 
ORT performance in APP/PS1 mice. No significant correlations were identified between 
IFN and IRS-1 pSer616 immunopositivity in the cortex or dentate gyrus (Fig. 7D and E). 
 
4. Discussion 
This study showed that peripheral glucose tolerance and insulin sensitivity were comparable 
between aged APP/PS1 and wild type mice, conflicting with a number of other studies (24, 
25). It has been suggested that 5/6 hours fasting is optimal for glucose and insulin tolerance 
tests, as this was sufficient for normalization of glucose levels and phosphorylation of insulin 
signaling proteins (26, 27). The current study performed glucose tolerance and insulin 
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sensitivity tests following an overnight fasting period, so it is possible that results presented 
here reflect an exaggerated suppression of basal glucose levels in mice as a result of 
prolonged fasting. This suggestion is supported by Jimenez-Palomares et al. (28) who also 
found that glucose tolerance and insulin sensitivity were not significantly different in 8 
month-old APP/PS1 mice, compared to wild types following overnight fasting periods. 
Future studies should avoid overnight fasting prior to glucose and insulin tolerance tests in 
order to achieve optimal normalization of metabolic parameters and to avert potentially 
dangerous hypoglycemic effects of insulin. Other reports suggest that insulin insensitivity 
and glucose intolerance also exists in aged animals (29-31), including C57Bl/6 mice (32-34); 
a possible explanation for the similarity between APP/PS1 mice and controls in the present 
study. To better understand the impact of central insulin resistance on global insulin 
utilisation in the APP/PS1 model, future studies should assess the impact of hypothalamic 
insulin administration alone and in combination with insulin sensitising drugs, such as 
metformin, in hyperinsulinemic euglycemic clamp models.  
Recognition memory was impaired in APP/PS1 mice here, consistent with several 
other studies (35-37). However, since wild type controls also exhibited impaired recognition 
memory, the deficits may be related to advanced age, rather than the APP/PS1 genotype; a 
suggestion supported by other studies reporting recognition memory deficits in aged C57Bl/6 
mice (38, 39). Another study found several indications of cognitive dysfunction in 18-20 
month-old C57Bl/6 mice, including impaired novel location memory, but not object 
recognition memory (40). Spatial learning was impaired in aged APP/PS1 mice, in agreement 
with other studies (41, 42). Spatial memory recall was impaired in APP/PS1 mice and wild 
type mice, similar to Barreto et al. (43), who showed that spatial learning and memory were 
impaired in 18 month-old C57Bl/6 mice. Other reports have highlighted age-related decline 
in learning and memory in C57Bl/6 mice (44, 45) consistent with the findings of the present 
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study, providing further evidence that there exists age-related deterioration of cognitive 
function in C57Bl/6 mice. Learning in the reversal water maze task was impaired in aged 
APP/PS1 mice, compared to controls, while both APP/PS1 mice and wild types failed to 
recognize the reversal target quadrant. Some (46), but not others (47) have shown that 
reversal learning and memory are impaired in APP/PS1 mice. Results presented here, suggest 
that reversal learning is a cognitive domain that is especially vulnerable to the effects of AD 
pathology in aged mice.  
Amyloid- (A) deposits were detected throughout the brains of 15-18 month-old 
APP/PS1 mice, while A was undetectable in wild type controls. APP/PS1 mice develop 
plaque deposition by 6 months of age, which progressively worsens, leading to abundant and 
widespread A plaque pathology by the age of 14 months (48, 49). The finding that A 
deposition was significant in APP/PS1 brains and absent from wild types suggests that the 
spatial memory deficits in both groups were not directly related to A burden. 
Oxidative stress levels were similar between APP/PS1 and wild type mice in the 
cortex and dentate gyrus. This was unexpected given previous reports showing elevated 
oxidative damage in brains of aged APP/PS1 mice (50-52). However, since aging is 
associated with accumulation of oxidative stress in the brain (53, 54), results presented here 
may reflect age-related accumulation of oxidative DNA damage in both APP/PS1 and wild 
type mice.  
IRS-1 pSer
616 
was increased in brains of APP/PS1 mice, as has also been observed in 
AD patients (18, 19, 55) and in experimental models (55, 56). The findings of the present 
study corroborate those of Talbot et al. (18) that demonstrated elevated IRS-1 pSer
616 
in the 
hippocampus of APP/PS1 mice. IRS-1 pSer
616 
has been shown to robustly correlate with 
cognitive impairment and brain insulin resistance associated with AD (18) and is likely 
related to the cognitive impairment in APP/PS1 mice here. It is interesting to note that the 
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increased brain insulin resistance in aged APP/PS1 mice was apparent in the absence of any 
significant indications of peripheral insulin insensitivity or glucose intolerance. 
Astrocytes were increased in the cortex and dentate gyrus of APP/PS1 mice, 
consistent with previous reports (50, 57). Neuroinflammation and glial cell proliferation, 
recruitment and activation is a commonly associated with AD pathology (13). The fact that 
A deposition remained substantial in the brains of APP/PS1 mice suggests that clearance of 
A was minimal, providing support for the proposal that astrocyte function is defective in 
AD (58). EAlthough expression of several inflammatory and insulin signaling genes was 
similar in brains of aged APP/PS1 mice and age-matched wild type controls. , comparison 
with younger control mice showed that IKK, ERK2 and mTOR were reduced, while TLR4 
was increased in brains of APP/PS1 mice compared to young wild types. It has been shown 
previously that expression of TLR4 is up-regulated in brains of APP/PS1 and wild type mice 
in an age-related manner (59) and the present report provides further evidence that TLR4 
expression in brain is increased with normal aging, to levels comparable with APP/PS1 mice. 
Th1 cytokine IFN was elevated in brains of APP/PS1 mice compared to young and old wild 
types, in agreement with another study that showed age-related enhancement of IFN in 
brains of AD mice from 3 to 19 months of age (60). It has also been shown that IFN has 
opposing functions in AD brain, whereby overexpression of IFN in the hippocampus 
augments neuroinflammation and worsens A burden, but abrogates tau pathology and 
enhances synaptic markers and neurogenesis (61). Further experimentation should determine 
whether the increased IFN in brains of APP/PS1 mice here represents a component of 
pathogenic neuroinflammation or an up-regulation of protective processes. A significant 
negative correlation was identified here between IFN levels and novel object recognition 
memory in APP/PS1 mice, in line with a recent study demonstrating improved hippocampal 
synaptic plasticity and cognitive performance in mice deficient for IFN (62), suggesting that 
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increased IFN in the brain may impair cognitive function in aged APP/PS1 mice. The 
increase in IFN is mirrored by a comparable increase in anti-inflammatory IL-4 in brains of 
APP/PS1 mice, which likely reflects an attempt to suppress the Th1 response.  Interestingly 
IFN has also been implicated in attenuation of insulin signaling (63) and may be similarly 
associated with the brain insulin resistance in the present study. Although we failed to detect 
significant correlations between brain levels of IFN and IRS-1 pSer616, this potential 
mechanism certainly warrants further exploration.  
Previous studies have detected increased IL-1 in the brains of APP/PS1 mice (64, 
65) in agreement with the present report. The present report, however, detected a non-
significant trend towards an increase in IL-1 in the brains of APP/PS1 mice, possibly due to 
a parallel, age-related elevation of IL-1 in wild-type mice. It has been demonstrated that A 
stimulates IL-1 production and secretion via NLRP3-dependent cleavage of pro-IL-1 by 
caspase-1 (66, 67). It is also interesting to note that IL-1 is the only one of all cytokines 
measured that was increased in both aged APP/PS1 and wild type mice, compared to young 
wild types. This suggests that IL-1 is involved with neuroinflammation that accompanies 
normal aging, while IFN and IL-4 are not part of the normal process of aging, but are 
components of the neuroinflammatory processes associated with AD, since these were 
elevated in aged APP/PS1 mice, compared to both young and old wild types. 
Expression of mTOR and ERK2 was reduced comparable in brains of aged APP/PS1 
mice, compared to young wild types. Extracellular signal-regulated kinase 2 (ERK2) 
signaling facilitates learning and memory (68, 69), suggesting that impaired cognitive 
function in aged mice may be due, in part to reduced expression of ERK2 in the brain. 
Dineley et al. (70) showed that A reduces ERK2 activity and that ERK2 expression is 
down-regulated in brains of 20 month-old AD mice, similar to results presented here. 
Similarly, dysregulation of signaling downstream of mTOR has been demonstrated in post-
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mortem brain tissue from AD patients (71), consistent with the reduced mTOR expression in 
APP/PS1 brain shown here. Signaling through mTOR contributes to synaptic plasticity, 
learning and memory (72, 73). It has also been shown that insulin promotes neurogenesis, 
dendrite and synapse formation by signaling through IRS-mediated activation of mTOR (74, 
75). Amyloid- (A) perturbs mTOR signaling in neurons (76) and mTOR inhibition impairs 
hippocampal LTP in an AD mouse model (77). Our results suggest that expression of insulin 
signaling components is comparable in aged APP/PS1 and wild-type mice. Disruption of 
insulin signaling in the brain may be involved in the pathophysiology of AD and may 
contribute to cognitive impairments associated with aging, a proposition that should be 
further probed in future studies.  
Synaptophysin staining was reduced in the polymorphic layer of the dentate gyrus of 
APP/PS1 mice. Several previous studies have shown that synapse density is decreased in the 
brains of APP/PS1 mice (78-80). These studies did not consider the discrete cellular layers of 
the hippocampus and may have overlooked subtle variation in synapse density between 
subregions (78-80). However, one report showed that synaptophysin levels in the 
hippocampus of 7 and 17 month-old APP/PS1 mice were similar to age-matched wild types 
(81), which more closely aligns with the findings of the present study. It has also been shown 
in Tg2576 mice, that synaptophysin levels were no different from controls at 3, 9, 14 and 19 
months of age (82), while Xu et al. (45) reported age-related decline in hippocampal synaptic 
spine density in C57Bl/6 mice. Results of the present report reflect a similar pattern, with 
synapse density being comparable to wild types in 15-18 month-old APP/PS1 mice. Since 
synapse density in the polymorphic layer was reduced in aged transgenic mice, it is 
reasonable to suggest that this subregion was selectively susceptible to synaptotoxicity 
associated with AD neuropathology.  
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A limitation of the present study is the absence of young cohorts of wild type and 
APP/PS1 mice. Based on evidence from the literature, it is likely that peripheral insulin 
sensitivity, cognitive function and synapse density were influenced by aging. Future studies 
should include groups of young wild type and transgenic mice in order to more robustly 
characterize the differences between AD pathology and changes associated with normal 
aging, throughout the lifecourse. Another limitation of the present report is that cytokines and 
mRNA were measured in whole hemi-brains, while analysis of immunohistochemistry was 
performed on brain sections allowing for quantification within discrete brain regions. This 
means that comparing the results of our biochemical assays with our immunohistochemical 
data is difficult. Future studies will analyse mRNA and associated proteins and activation 
states in discrete brain regions to allow for more accurate demarcation of differences between 
APP/PS1 mice and wild types with regard to insulin signaling dysregulation and 
inflammation the brain.  
 Nevertheless, this study has demonstrated memory deficits and neuroinflammation in 
aged APP/PS1 and wild type mice. Astrocyte accumulation, IL-1 and IRS-1 pSer616 levels 
were increased in the brain of APP/PS1 mice in the absence of systemic insulin insensitivity 
or glucose intolerance. Pharmacological agents targeting impaired insulin signaling and 
inflammation in the brain may prove efficacious in treating AD, a suggestion requiring 
further investigation. 
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Figure Legends 
Figure 1. Learning and memory in aged APP/PS1 and wild type mice. The acquisition 
training phase of the Morris water maze (MWM) involved four training sessions per day 
over four consecutive days, followed by a probe trial on the fifth day, 24 hours following the 
final training session. Escape latency during the training phase is shown (A), as is the 
proportion of time spent in each quadrant during the probe trial by 15-18 month-old wild 
type (solid line with circles; D) and APP/PS1 (dotted line with squares; G) mice. Reversal 
water maze acquisition training began 24 hours following the MWM probe trial and 
consisted of four consecutive days with four training sessions per day, followed by a reversal 
probe trial on the fifth day. Illustrated are training phase escape latency (B) and time spent in 
each quadrant during the reversal probe trial by wild type (E) and APP/PS1 (H) mice. For 
the novel object recognition task, recognition index, a measure of the percentage of time 
spent exploring either object, is illustrated in the acquisition phase (C) during exposure to 
two identical objects, and the test phase (F), in the presence of one familiar (black bars) and 
one novel (white bars) object. *p<0.05, **p<0.01 APP/PS1 vs. wild type; . Data represent 
mean ± SEM for 13-15 mice per group, two-way repeated measures ANOVA with 
Bonferroni’s post-hoc test (A, B), ordinary one-way ANOVA with Dunnett’s post-hoc test 
(D, E, G, H), multiple t tests with Holm-Šídák’s post-hoc test (C, F). Data represent mean ± 
SEM for 13-15 mice per group. 
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Figure 2. A deposition and IRS-1 pSer616 in the cerebral cortex and dentate gyrus of 
aged APP/PS1 and wild type mice. Representative images (10x magnification) are shown 
that depict A staining in the cerebral cortex (A) and dentate gyrus (B) of 15-18 month old 
wild type mice and the cerebral cortex (E) and dentate gyrus (F) of age-matched APP/PS1 
mice. Also shown is an exemplary magnified image (20x magnification) of A staining in 
brains of wild type (C) and APP/PS1 (G) mice. Quantification of A immunopositivity in 
the cortex (D) and dentate gyrus (H) of 15-18 month old APP/PS1 and wild type mice is also 
shown. Representative images (20x magnification) are also shown that depict IRS-1 pSer
616 
staining in the cerebral cortex (I) and dentate gyrus (J) of 15-18 month old wild type mice 
and the cerebral cortex (M) and dentate gyrus (N) of age-matched APP/PS1 mice. Also 
shown are exemplary magnified images (40x magnification) from wild type (K) and 
APP/PS1 (O) mice. Quantification of IRS-1 pSer
616
 immunopositivity in cortex (L) and 
dentate gyrus (P) of 15-18 month old APP/PS1 and wild type mice is also illustrated. 
*p<0.05, ****p<0.0001, Student’s t test. Data represent mean ± SEM for 6 per group. 
 
Figure 3. Oxidative stress and astrocytes in the cerebral cortex and dentate gyrus of 
aged APP/PS1 and wild type mice. Representative images (20x magnification) are shown 
that depict the 8-oxoguanine staining in cerebral cortex (A) and dentate gyrus (B) of 15-18 
month old wild type mice and cerebral cortex (E) and dentate gyrus (F) of age-matched 
APP/PS1 mice. Also shown are exemplary magnified images (40x magnification) from wild 
type (C) and APP/PS1 (G) mice. Quantification of 8-oxoguanine immunopositivity in cortex 
(D) and dentate gyrus (H) of 15-18 month old APP/PS1 and wild type mice is also 
illustrated. Representative images (20x magnification) are also shown that depict GFAP 
staining in the cerebral cortex (I) and dentate gyrus (J) of 15-18 month-old wild type mice 
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and the cerebral cortex (M) and dentate gyrus (N) of age-matched APP/PS1 mice. Also 
shown are exemplary magnified images (100x magnification) from wild type (K) and 
APP/PS1 (O) mice. Quantification of GFAP immunopositivity in cortex (L) and dentate 
gyrus (P) of 15-18 month old APP/PS1 and wild type mice is also shown. ***p<0.001;, 
Student’s t test. Data represent mean ± SEM for 6 per group. 
 
Figure 4. Synapse density is decreased in the polymorphic layer of the dentate gyrus in 
APP/PS1 mice. Illustrated are representative images depicting synaptophysin staining of 
brain sections from 15-18 month-old wild type (A, B, C) and APP/PS1 (D, E, F) mice. A 
and D show the polymorphic layer (PL), granule cell layer (GCL) and molecular layer (ML) 
of the dentate gyrus. C and D show the stratum radiatum (SR), stratum pyramidale (SP) and 
stratum oriens (SO) of the hippocampus, while B and E show the inner (IC) and outer (OC) 
cerebral cortex. Also illustrated is quantification of synaptophysin optical density values for 
the polymorphic layer, granule cell layer and molecular layer of the dentate gyrus and the 
stratum radiatum, stratum pyramidale and stratum oriens of the hippocampus, inner and outer 
cortex of 15-18 month-old APP/PS1 and wild type mice (G). *p<0.05;, Student’s t tests. 
Data represent mean ± SEM for 6 per group. 
 
Figure 5. Peripheral insulin sensitivity, glucose tolerance and expression of 
inflammatory and insulin signaling genes in brains of aged APP/PS1 mice. Illustrated is 
quantification of the expression of genes associated with inflammatory pathways and insulin 
signaling in brains of 15-18 month-old APP/PS1 mice (black bars), compared with age-
matched wild type controls (white bars) (A). Also shown is quantification of expression of 
the same genes in aged APP/PS1 and wild type mice, compared with 17-22 week-old wild 
types (dark grey bars) (B). Also shown are blood glucose levels following insulin injection 
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(BC) and following glucose injection (CD). Wild type (solid line with circles) and APP/PS1 
mice (dotted line with squares) aged 15-18 months were administered insulin or glucose via 
i.p. injection and blood glucose levels were measured at 15, 30 and 60 minutes post-injection. 
*p<0.05, **p<0.01. Data represent mean ± SEM for 5 per grou; p, ordinary two-way 
ANOVA with Holm-Šídák’s post-hoc test (A, B) or 13-15 per group, two-way repeated 
measures ANOVA with Holm-Šídák’s post-hoc test (BC, CD). Data represent mean ± SEM 
for 5 per group. 
 
Figure 6. Cytokine levels in the brains of aged APP/PS1 and wild type mice. MSD 
multiplex analysis of 8 cytokines was performed on supernatant extracted from brain tissue. 
Protein levels of IFN (A), IL-10 (B), IL-1 (C), IL-12p70 (D), IL-2 (E), IL-4 (F), IL-5 (E), 
IL-6 (G) and KC/GRO (CXCL1) (H) were measured and compared between 15-18 month-
old APP/PS1 mice (black bars) and, age-matched wild types (white bars). and younger mice, 
aged 17-22 weeks (dark grey bars). **p<0.01; Student’s t tests. , ***p<0.001, 
****p<0.0001. Data represent mean ± SEM for 6 per group., ordinary one-way ANOVA 
with Holm-Šídák’s post-hoc test. 
 
Figure 7. Correlations between IFN, IRS-1 pSer616 and novel object recognition 
memory in aged APP/PS1 and wild type mice. Pearson’s correlation analysis was 
performed between IRS-1 pSer
616 
immunopositivity and novel object recognition index (A, 
B), between IFN and novel object recognition index (C) and between IFN and IRS-1 
pSer
616 
immunopositivity (D, E) in wild type (open circles and dotted best fit line) and 
APP/PS1 (black squares and solid best fit line) mice. Lines of best fit, r and p values were 
also added to the graphs. Each data point represents an XY pair for a total of 6 XY pairs per 
genotype on each graph. Significance of correlation was determined using two-tailed t tests. 
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Supplementary Figure 1. Cytokines and gene expression in brains of young wild type 
mice. Quantification of expression of inflammatory and insulin signaling genes in the brains 
of young wild type mice (17-22 weeks old) is shown (black bars), compared to aged wild 
types (white bars) and APP/PS1 mice (dark grey bars) (A). Also illustrated are brain levels of 
IFN (B), IL-1 (C) and IL-4 (D) in young wild type mice, compared with aged wild types 
and APP/PS1 mice. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; ordinary one-way 
ANOVA with Holm-Šídák’s post-hoc test (A) and Student’s t test (B-D). Data represent 
mean ± SEM for 5 (A) or 6 (B-D) per group. 
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